High materiality7/10
PTC Therapeutics price target lowered to $75 from $85 at RBC Capital
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
RBC lowers PTCT target to $75 from $85; current price about $62.45, leaving upside potential.
- RBC lowers PTCT target to 75; price 62.45
Key facts
- 01
Target: $75
- 02
Posted price: $62.45
- 03
Analyst firm: RBC Capital
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.